EVH — Evolent Health, Inc
Is EVH overbought or oversold? Here is the current MarketMoodz read.
Evolent Health, Inc (EVH) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Healthcare name (Health Information Services) last closed at $4.83. The rating moved from Neutral to Overbought on November 14, 2026.
- Public ratingOverbought (as of November 17, 2026)
- Last close$4.83
- Last changeMoved from Neutral to Overbought on November 14, 2026
- SectorHealthcare
- IndustryHealth Information Services
See all overbought Healthcare stocks →
AI analysis
Evolent Health, Inc (EVH) operates a differentiated value-based care services and technology platform that benefits from payors' drive to expand Medicare Advantage offerings and outsource utilization management. Revenue is driven by contracted managed services and technology subscriptions, offering potential margin upside as scale and cost discipline improve. Near-term catalysts include new client wins, retention of large payors, and evidence of margin recovery. Key concerns are client concentration, sensitivity to reimbursement/regulatory changes, execution risk on integrations, and cash-flow variability that could necessitate capital actions. Overall outlook is balanced: upside exists if contracts scale and margins improve, while downside is meaningful if reimbursement dynamics or execution falter.
Key factors
- Positioning in value-based care and managed services for payors and provider systems provides recurring contract revenue and long-term addressable demand as Medicare Advantage expands.
- Exposure to Medicare Advantage tailwinds: $0‑premium and richer benefit trends can drive payer demand for operational partners that manage utilization and costs.
- Revenue mix includes managed services and technology subscriptions which can scale and produce margin leverage if client book grows and utilization management improves.
- Recent sector readthroughs (specialty distribution, outpatient shift) indirectly support broader demand for outsourced care management and service platforms.
- Earnings and cash-flow variability historically have created sensitivity around quarterly results; near-term performance will hinge on contract wins, retention, and cost discipline.
Risks
- Client concentration risk and contract re-pricing or non-renewal by large payor clients could materially affect revenue.
- Reimbursement and regulatory shifts in Medicare Advantage or state Medicaid programs could reduce expected savings or change incentives for clients.
- Margin pressure from richer benefit offerings, inflation in medical costs, or mis-execution on cost controls may compress profitability.
- Execution risk on technology integrations and scaling managed-service operations; delays or underperformance would hurt growth and margins.
- Liquidity and capital-structure risks, including potential dilution or need for financing, particularly if cash flow underperforms expectations.
- Short-term market sensitivity to earnings beats/misses given limited social/research coverage and potential retail/quant flows.
See today's live rating, score and targets
Members see the live hourly rating for EVH — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.